Details of the Drug

General Information of Drug (ID: DMVTDQ8)

Drug Name
Porfiromycin
Synonyms Porfiromycine; Promycin; ENT-50825; N-methylmitomycin C; U-14743
Indication
Disease Entry ICD 11 Status REF
Head and neck cancer 2D42 Phase 3 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C16H20N4O5
Canonical SMILES
CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4C)N
InChI
1S/C16H20N4O5/c1-6-10(17)13(22)9-7(5-25-15(18)23)16(24-3)14-8(19(14)2)4-20(16)11(9)12(6)21/h7-8,14H,4-5,17H2,1-3H3,(H2,18,23)/t7-,8+,14+,16-,19?/m1/s1
InChIKey
HRHKSTOGXBBQCB-VFWICMBZSA-N
Cross-matching ID
PubChem CID
13116
CAS Number
801-52-5
TTD ID
D0PM9D
Combinatorial Drugs (CBD) Click to Jump to the Detailed CBD Information of This Drug

References

1 ClinicalTrials.gov (NCT02183246) Porfiromycin Used as an Adjuvant to Radiation Therapy in Postoperative Head and Neck Cancer Patients. U.S. National Institutes of Health.